Patents by Inventor Matjaz BRVAR

Matjaz BRVAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tetrahydro-benzo[d]azepine derivatives as GPR120 modulators
    Patent number: 11220483
    Abstract: Novel tetrahydroisoquinoline and tetrahydrobenzazepine compounds of formula (I) capable of modulating the G-protein-coupled receptor GPR120, compositions comprising the compounds, and methods for their use for controlling insulin levels in vivo and for the treatment of conditions such as of diabetes, inflammation, obesity and metabolic diseases.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: January 11, 2022
    Assignee: CALDAN THERAPEUTICS LTD
    Inventors: Jane Brown, Stephen Connolly, Steffen V. F. Hansen, Gavin Milne, Bharat Shimpukade, Don Smyth, Gerard Thomas, Trond Ulven, Matjaz Brvar, Aaron Rigby
  • TETRAHYDRO-BENZO[D]AZEPINE DERIVATIVES AS GPR120 MODULATORS
    Publication number: 20200317619
    Abstract: Novel tetrahydroisoquinoline and tetrahydrobenzazepine compounds of formula (I) capable of modulating the G-protein-coupled receptor GPR120, compositions comprising the compounds, and methods for their use for controlling insulin levels in vivo and for the treatment of conditions such as of diabetes, inflammation, obesity and metabolic diseases.
    Type: Application
    Filed: March 26, 2018
    Publication date: October 8, 2020
    Inventors: Jane BROWN, Stephen CONNOLLY, Steffen V.F. HANSEN, Gavin MILNE, Bharat SHIMPUKADE, Don SMYTH, Gerard THOMAS, Trond ULVEN, Matjaz BRVAR, Aaron RIGBY